Patients With Borderline Resectable Pancreatic Cancer
1 clinical trials · Condition
◉ Watch Patients With Borderline Resectable Pancreatic Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study (NCT02148549) | Wakayama Medical University | 2014-04-01 |
Track Patients With Borderline Resectable Pancreatic Cancer automatically
Every clearance here is in the API, with alerts when new ones post.